Ucb Biopharma Srl

This study looks at the long-term safety of a drug called dapirolizumab pegol for people with systemic lupus erythematosus (lupus). About 760 adults who completed a previous related study will receive the drug and be monitored for side effects. The goal is to see if the drug is s…

This study looks at the long-term safety and effectiveness of a drug called bimekizumab for people with active axial spondyloarthritis, a type of arthritis that mainly affects the spine. About 500 adults who completed a previous bimekizumab study will continue taking the drug for…

This study tests whether bimekizumab is more effective than risankizumab for adults with active psoriatic arthritis. About 684 participants will receive one of the two drugs, and researchers will measure joint pain, swelling, and skin symptoms after 16 weeks. Both drugs are alrea…

This study looks at the long-term safety of a drug called rozanolixizumab in children aged 2 and older with generalized myasthenia gravis, a condition that causes muscle weakness. Participants who completed a previous study can join. The main goal is to track serious side effects…

This study looks at the long-term safety of bimekizumab in 658 adults with moderate to severe hidradenitis suppurativa, a chronic skin disease causing painful boils. Participants had already completed a year of treatment in earlier studies. The main goal is to track side effects …

This study looks at the long-term safety and effectiveness of a drug called bimekizumab for adults with active psoriatic arthritis. About 1,100 participants who completed earlier studies will receive the drug as an injection. The goal is to see how well it controls symptoms over …

This study tests a drug called rozanolixizumab in adults with MOG-AD, a rare disease where the immune system attacks the brain and spinal cord, causing relapses. The goal is to see if the drug can prevent or delay these attacks. About 113 participants will receive either the drug…

This study looks at the long-term safety and effectiveness of the drug zilucoplan for people with generalized myasthenia gravis, a chronic muscle weakness condition. About 200 participants who completed a prior zilucoplan study will receive the drug and be monitored for side effe…

This early-stage study tests the safety and tolerability of an experimental drug called UCB0022 in 32 healthy adults of Caucasian, Japanese, and Chinese backgrounds. Participants receive either the drug or a placebo, and researchers monitor for side effects and how the drug moves…